Andrew Allen

Andrew Allen has a diverse work experience in various scientific roles. Andrew recently joined Empirico Inc. as a Principal Scientist in October 2022. Prior to that, they worked at Neumora as a Senior Scientist from August 2020 to October 2022. Andrew also worked at Broad Institute as a Senior Research Associate II from February 2014 to October 2022. Andrew has previous experience at Monte Rosa Therapeutics as a Scientist I from March 2020 to November 2020, Jnana Therapeutics as a Scientist I from November 2019 to February 2020, and as an Associate Scientist from October 2018 to November 2019. In addition, they worked at Dana-Farber Cancer Institute as a Lead Research Associate from May 2012 to January 2014 and at Massachusetts General Hospital as a Research Tech I-II from May 2009 to February 2012.

Andrew Allen attended Marshfield High School from 2000 to 2004. Andrew then pursued a Bachelor of Science degree in Biochemistry and Molecular Biology at UMass Amherst, graduating in 2008. Andrew continued their education at UMass Amherst and obtained a Master of Science degree in Biochemistry and Molecular Biology in 2009.